Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Basilea Pharmaceutica AG (SW: BSLN)

 
BSLN Technical Analysis
1
As on 9th Jun 2023 BSLN STOCK Price closed @ 45.75 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BSLNSTOCK Price

Open 45.40 Change Price %
High 46.15 1 Day N/A N/A
Low 45.05 1 Week 0.00 0.00
Close 45.75 1 Month 0.00 0.00
Volume 42554 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
SW Switzerland Most Active Stocks
CSGN 0.81 %
CSGN 0.81 %
MBTN 0.58 %
ABBN 34.50 %
ABBN 34.50 %
UBSG 18.20 %
UBSG 18.20 %
NOVN 90.17 %
NOVN 90.17 %
NESN 107.16 %
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CASN 1.90 8.57%
SKIN 32.50 8.33%
SKIN 32.50 8.33%
GUR 1258.00 2.78%
 
SW Switzerland Top Losers Stocks
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
LINN 585.00 -7.87%
ABT 91.50 -3.68%
 
 
BSLN
Daily Charts		 BSLN
Intraday Charts		 Whats New @
Bazaartrend		 BSLN
Free Analysis
 
BSLN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
BSLN Forecast September 2023
Share
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
BSLN Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
BSLN Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
BSLN Other Details
Segment EQ
Market Capital 500739264.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BSLN Address
BSLN
 
BSLN Latest News
 
Your Comments and Response on Basilea Pharmaceutica AG
 
BSLN Business Profile
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, the European Union, and internationally, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia in European and various non-European countries. In addition, it engages in developing Derazantinib, a small molecule inhibitor, which is in phase 2 clinical trial for bile duct cancer, as well as in phase ½ clinical trial for bladder and stomach cancer; and Lisavanbulin, a tumor checkpoint controller drug. The company was founded in 2000 and is headquartered in Basel, Switzerland. Address: Grenzacherstrasse 487, Basel, Switzerland, 4058
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service